Felicity E. B. May - Concepedia

Author

Felicity E. B. May

Newcastle University ORCID

Also Known As

F E B May, F E May, F MAY, F May, F. E. B. May, F. May, F.E. May, F.E.B May, F.E.B. May, FELICITY E. B. MAY

123

Publications

5.6K

Citations

H-Index

127

Concepts

All Affiliations

Newcastle University Royal Victoria Infirmary Inserm Novo Nordisk (Denmark)

About

Felicity E. B. May is an author at Newcastle University specializing in medicine, cell biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	55	3.4K
2	Natural Sciences	11	11	654
3	Health Sciences	5	5	338
4	Public Health	2	2	47
5	Engineering	1	1	83

Felicity E. B. May

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. Alistair Stewart, Michael D. Johnson, Felicity E. B. May, Journal of Biological Chemistry Breast OncologyGrowth HormoneEndocrine-related CancerInsulin-like Growth FactorsIgf Receptor Probe	1990	387
The estrogen‐regulated protein, TFF1, stimulates migration of human breast cancer cells Sara J. Prest, Felicity E. B. May, Bruce R. Westley The FASEB Journal Breast OncologyEstrogen‐regulated ProteinDimeric Tff1MedicineCancer Growth	2002	190
Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study James A. Henry, Anne L. McCarthy, Bill Angus, Cancer Tumor BiologyCathepsin DBreast OncologyEstrogen ReceptorEstrogen-regulated Lysosomal Protease	1990	148
Insulin Receptor Substrate-1 Expression Is Regulated by Estrogen in the MCF-7 Human Breast Cancer Cell Line Claire A. Molloy, Felicity E. B. May, Bruce R. Westley Journal of Biological Chemistry	2000	134
Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy Zoë Davison, Gail E. de Blacquière, Bruce R. Westley, Neoplasia Breast OncologyTriple-negative Breast CancersMedicineImmunologyCancer Growth	2011	124
Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase‐2 and EGF receptor signaling Sylvie Rodrigues, Elisabeth Van Aken, Saskia Van Bocxlaer, The FASEB Journal Tyrosine KinaseImmunologyCellular PhysiologyInflammationAngiogenesis	2003	120
Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells Bruce R. Westley, Felicity E. B. May Nucleic Acids Research	1987	118
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. B R Westley, Felicity E. B. May, Arthur Brown, Journal of Biological Chemistry Radiation OncologyBreast OncologyTamoxifen TreatmentEstrogen-regulated Ps2 RnaNatural Sciences	1984	117
NCL‐CB11, a new monoclonal antibody recognizing the internal domain of the c‐<i>erb</i>B‐2 oncogene protein effective for use on formalin‐fixed, paraffin‐embedded tissue Ian Corbett, James A. Henry, Brian Angus, The Journal of Pathology	1990	108
Induction of scattering and cellular invasion by trefoil peptides in src‐ and RhoA‐transformed kidney and colonic epithelial cells Shahin Emami, Erik Bruyneel, Lars Thim, The FASEB Journal	2001	106

Page 1